T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
BJ's Restaurants
BJRI
$1.45B
| $644K | ﹤0.01% |
18,539
-482
| -3% | -$16.5K |
|
2077
Coursera
COUR
$1.53B
| $644K | ﹤0.01% |
89,901
+16,296
| +22% | +$155K |
|
2078
Nuvation Bio
NUVB
$2.18B
| $644K | ﹤0.01% |
220,319
-1,134,313
| -84% | -$3.46M |
|
|
BDN
2079
Brandywine Realty Trust
BDN
$532M
| $640K | ﹤0.01% |
142,690
+4,359
| +3% | +$19.9K |
|
2080
CVR Energy
CVI
$3.54B
| $640K | ﹤0.01% |
23,874
+2,389
| +11% | +$72.6K |
|
|
RDFN
2081
DELISTED
Redfin
RDFN
| $640K | ﹤0.01% |
106,351
+14,925
| +16% | +$93.2K |
|
2082
Comstock Resources
CRK
$4.13B
| $639K | ﹤0.01% |
61,547
+2,726
| +5% | +$28.6K |
|
2083
National Healthcare
NHC
$3.5B
| $637K | ﹤0.01% |
5,876
-1,697
| -22% | -$165K |
|
|
RAPT
2084
DELISTED
RAPT Therapeutics
RAPT
| $637K | ﹤0.01% |
26,062
-227,459
| -90% | -$10.5M |
|
2085
TriMas Corp
TRS
$1.4B
| $636K | ﹤0.01% |
24,858
+988
| +4% | +$26K |
|
2086
Park Aerospace
PKE
$831M
| $634K | ﹤0.01% |
46,282
+4,578
| +11% | +$66K |
|
2087
AMERISAFE
AMSF
$513M
| $633K | ﹤0.01% |
14,414
+562
| +4% | +$25.8K |
|
|
TRTX
2088
TPG RE Finance Trust
TRTX
$609M
| $633K | ﹤0.01% |
73,212
-2,164
| -3% | -$17.7K |
|
2089
4D Molecular Therapeutics
FDMT
$637M
| $631K | ﹤0.01% |
30,044
+6,092
| +25% | +$153K |
|
2090
Atlanta Braves Holdings Series B
BATRK
$3.44B
| $629K | ﹤0.01% |
15,945
+2,950
| +23% | +$115K |
|
|
DMC
2091
Del Monte Corp
DMC
$1.43B
| $629K | ﹤0.01% |
28,787
+931
| +3% | +$22.4K |
|
2092
Intapp
INTA
$3.09B
| $629K | ﹤0.01% |
17,138
+989
| +6% | +$33.6K |
|
2093
SunCoke Energy
SXC
$794M
| $628K | ﹤0.01% |
64,012
+1,284
| +2% | +$13.3K |
|
|
HAPN
2094
Happen Inc
HAPN
$2.26B
| $626K | ﹤0.01% |
73,992
+3,277
| +5% | +$28K |
|
2095
AdaptHealth
AHCO
$775M
| $624K | ﹤0.01% |
62,389
+4,515
| +8% | +$45.9K |
|
2096
InMode
INMD
$872M
| $624K | ﹤0.01% |
34,119
-25,491
| -43% | -$468K |
|
|
PGRE
2097
DELISTED
Paramount Group
PGRE
| $624K | ﹤0.01% |
134,725
+5,254
| +4% | +$24.4K |
|
|
ALLK
2098
DELISTED
Allakos
ALLK
| $621K | ﹤0.01% |
620,457
-17,645
| -3% | -$21K |
|
2099
Gorman-Rupp
GRC
$2.13B
| $620K | ﹤0.01% |
16,867
+222
| +1% | +$7.84K |
|
2100
Vishay Precision Group
VPG
$969M
| $620K | ﹤0.01% |
20,360
+258
| +1% | +$8.46K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.